Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2Gastrointestinal 2

Conditions

Stomach Neoplasms 57Carcinoma, Hepatocellular 45Colorectal Neoplasms 18Esophageal Squamous Cell Carcinoma 10Cholangiocarcinoma 10Esophageal Neoplasms 9Advanced Gastric Cancer 9Biliary Tract Neoplasms 8Pancreatic Neoplasms 6Liver Neoplasms 5Neoplasms 3Neoplasm Metastasis 3Gastrointestinal Neoplasms 3Gastric Adenocarcinoma 3Digestive System Neoplasms 3Recurrence 2Metastatic Gastric Adenocarcinoma 2Locally Advanced Gastric Cancer 2Gastrointestinal Stromal Tumors 2Advanced Esophagus Cancer 2Uterine Cervical Neoplasms 1Stomach Diseases 1Resectable Intrahepatic Cholangiocarcinoma With High Risk of Recurrence 1Peritoneal Metastases From Gastric Cancer 1Ovarian Neoplasms 1Locally Advanced or Metastatic Gastric Adenocarcinoma 1Intestinal Neoplasms 1Immunotherapy Gastrict Cancer 1Immunotherapy 1Hepatic Metastasis of Colorectal Cancer 1

Interventions

Imatinib Mesylate 71Sunitinib 31regorafenib 17nilotinib 15ripretinib 13avapritinib 7Laparoscopy 5Ipilimumab 5Dasatinib 5spartalizumab 4CTLA-4 Antigen 4Blood Specimen Collection 44-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 4pexidartinib 3pazopanib 3binimetinib 3Temozolomide 3Surveys and Questionnaires 3Surgical Procedures, Operative 3Paclitaxel 3Oxaliplatin 3Observation 3Nivolumab 3Midazolam 3Leucovorin 3Gemcitabine 3Biopsy 3Bevacizumab 3trametinib 2tanespimycin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Gastrointestinal Stromal Tumors × apatinib × Gastrointestinal × Clear all
NCT05905887 2026-04-07

Rivoceranib Plus Paclitaxel in Patients With Gastrointestinal Stromal Tumor

Asan Medical Center

Phase 2 Recruiting
48 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT05751733 2023-03-02

Apatinib Mesylate Versus Standard Second-line TKI in the Treatment of Advanced GIST

Xiangya Hospital of Central South University

Phase NA Recruiting
258 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡